Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use
US9475888B2 · kind B2 · utility
0Cited by
13References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2012 |
| Grant date | Oct 25, 2016 |
| Priority date | — |
| Expiry date | Apr 26, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a chemically modified glycosaminoglycan with an antifactor II activity of less than 10 IU/mg, an antifactor Xa activity of less than 10 IU/mg and an average molecular weight (Mw, weight average) from about 4.6 to 6.9 kDa. Also disclosed is a method of preparing the modified glycosaminoglycan and its medical uses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.